• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺活检:现状与局限性

Prostate biopsy: current status and limitations.

作者信息

Presti Joseph C

机构信息

Department of Urology, Stanford University School of Medicine Stanford, CA.

出版信息

Rev Urol. 2007 Summer;9(3):93-8.

PMID:17934565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2002498/
Abstract

The technique of prostate biopsy has evolved over the past 10 years to improve our ability to detect prostate cancer. Extended biopsy schemes can be performed in the office under local anesthesia and are well tolerated. In addition to detection, the role of extended biopsy schemes in refining tumor grading and risk assessment has become better defined. This review discusses the evolution of prostate biopsy techniques from the sextant scheme to the extended scheme and demonstrates the latter's utility in clinical decision making.

摘要

在过去十年中,前列腺活检技术不断发展,以提高我们检测前列腺癌的能力。扩展活检方案可在门诊局部麻醉下进行,患者耐受性良好。除了检测外,扩展活检方案在细化肿瘤分级和风险评估方面的作用也得到了更明确的界定。本文综述了前列腺活检技术从六分区方案到扩展方案的演变,并展示了扩展方案在临床决策中的实用性。

相似文献

1
Prostate biopsy: current status and limitations.前列腺活检:现状与局限性
Rev Urol. 2007 Summer;9(3):93-8.
2
Role of prostate biopsy schemes in accurate prediction of Gleason scores.前列腺活检方案在准确预测 Gleason 评分中的作用。
Urology. 2006 Feb;67(2):379-83. doi: 10.1016/j.urology.2005.08.018.
3
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.扩展前列腺活检方案提高了 Gleason 分级的可靠性:对放疗患者的影响
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014.
4
[Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].[基于问卷的不同活检方案前列腺穿刺活检并发症评估]
Arch Ital Urol Androl. 2003 Mar;75(1):40-5.
5
Comparison of prostate biopsy schemes by computer simulation.
Urology. 1999 May;53(5):951-60. doi: 10.1016/s0090-4295(98)00639-6.
6
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.系统活检方法在前列腺癌诊断中的价值:一项系统评价
J Urol. 2006 May;175(5):1605-12. doi: 10.1016/S0022-5347(05)00957-2.
7
Detection of prostate cancer: comparison of cancer detection rates of sextant and extended ten-core biopsy protocols.前列腺癌的检测:六分区活检与扩展十针活检方案的癌症检测率比较
Niger Postgrad Med J. 2012 Sep;19(3):137-42.
8
A comparison of extended biopsy and sextant biopsy schemes for predicting the pathological stage of prostate cancer.
J Urol. 2004 Jun;171(6 Pt 1):2203-8. doi: 10.1097/01.ju.0000127729.71350.7f.
9
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.以最少的核心数进行活检,以检测到 24 核心活检检测到的 95%的前列腺癌。
Eur Urol. 2010 Jan;57(1):1-8. doi: 10.1016/j.eururo.2009.08.011. Epub 2009 Aug 19.
10
Update on prostate biopsy technique.
Curr Opin Urol. 2004 May;14(3):157-62. doi: 10.1097/00042307-200405000-00004.

引用本文的文献

1
Shape Manipulation of Bevel-Tip Needles for Prostate Biopsy Procedures: A Comparison of Two Resolved-Rate Controllers.用于前列腺活检程序的斜面尖端针的形状操纵:两种分辨率控制器的比较
Annu Int Conf IEEE Eng Med Biol Soc. 2024 Jul;2024:1-7. doi: 10.1109/EMBC53108.2024.10781867.
2
Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies.机器学习模型在减少不必要的靶向前列腺活检中的比较性能
Eur Urol Oncol. 2025 Feb 8. doi: 10.1016/j.euo.2025.01.005.
3
Understanding Spatial Correlation Between Multiparametric MRI Performance and Prostate Cancer.理解多参数 MRI 性能与前列腺癌之间的空间相关性。
J Magn Reson Imaging. 2024 Nov;60(5):2184-2195. doi: 10.1002/jmri.29287. Epub 2024 Feb 12.
4
[MR-Guided Targeted Prostate Biopsy from Radiologists' Perspective].[从放射科医生角度看磁共振引导下靶向前列腺穿刺活检]
J Korean Soc Radiol. 2023 Nov;84(6):1220-1232. doi: 10.3348/jksr.2023.0095. Epub 2023 Nov 15.
5
The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment.动态 T 细胞状态与免疫检查点阻断疗法在外周和肿瘤微环境中的交汇。
Front Immunol. 2023 Oct 10;14:1267918. doi: 10.3389/fimmu.2023.1267918. eCollection 2023.
6
Fully automated detection and localization of clinically significant prostate cancer on MR images using a cascaded convolutional neural network.使用级联卷积神经网络在磁共振图像上全自动检测和定位具有临床意义的前列腺癌。
Front Oncol. 2022 Sep 29;12:958065. doi: 10.3389/fonc.2022.958065. eCollection 2022.
7
MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed.MRI 靶向活检核心从前列腺指数病变:评估和预测的需要数量。
Prostate Cancer Prostatic Dis. 2023 Sep;26(3):543-551. doi: 10.1038/s41391-022-00599-2. Epub 2022 Oct 8.
8
Prostate zones and cancer: lost in transition?前列腺区与癌症:迷失在转化中?
Nat Rev Urol. 2022 Feb;19(2):101-115. doi: 10.1038/s41585-021-00524-7. Epub 2021 Oct 19.
9
Design of an Ultrasound-Navigated Prostate Cancer Biopsy System for Nationwide Implementation in Senegal.用于在塞内加尔全国推广的超声导航前列腺癌活检系统的设计
J Imaging. 2021 Aug 20;7(8):154. doi: 10.3390/jimaging7080154.
10
What is the consistency between the results of needle biopsy and prostatectomy specimen pathology results? A pilot study.针吸活检与前列腺切除术标本病理结果的一致性如何?一项初步研究。
Turk J Med Sci. 2021 Jun 28;51(3):1360-1364. doi: 10.3906/sag-2009-73.

本文引用的文献

1
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.用于接受重复活检男性前列腺癌的PCA3分子尿液检测
Urology. 2007 Mar;69(3):532-5. doi: 10.1016/j.urology.2006.12.014.
2
Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.前列腺穿刺活检标本的升级与降级:危险因素及临床意义。
Urology. 2007 Mar;69(3):495-9. doi: 10.1016/j.urology.2006.10.036.
3
Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.作为初始前列腺活检策略,饱和技术并不能提高癌症检测率。
J Urol. 2006 Feb;175(2):485-8. doi: 10.1016/S0022-5347(05)00211-9.
4
uPM3, a new molecular urine test for the detection of prostate cancer.uPM3,一种用于检测前列腺癌的新型分子尿液检测方法。
Urology. 2004 Aug;64(2):311-5; discussion 315-6. doi: 10.1016/j.urology.2004.03.052.
5
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.扩展前列腺活检方案提高了 Gleason 分级的可靠性:对放疗患者的影响
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014.
6
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.欧洲前列腺癌筛查随机研究鹿特丹分部中前列腺特异性抗原的变化
Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028.
7
Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.既往活检方案对重复活检时检测到的癌症病理特征的影响。
Urol Oncol. 2004 Jan-Feb;22(1):7-10. doi: 10.1016/S1078-1439(03)00147-9.
8
The utility of apical anterior horn biopsies in prostate cancer detection.
Urol Oncol. 2003 Sep-Oct;21(5):361-5. doi: 10.1016/s1078-1439(03)00031-0.
9
Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.前列腺穿刺活检组织中癌灶所占百分比是前列腺癌根治术后前列腺特异性抗原复发的重要独立预测因素:来自SEARCH数据库的结果
J Urol. 2003 Jun;169(6):2136-41. doi: 10.1097/01.ju.0000065588.82511.06.
10
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.结合活检侧别与TNM分期的改良临床分期系统用于T1c和T2期前列腺癌男性患者:SEARCH数据库的结果
J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14.